Severe hemophagocytic syndrome after intravesical BCG instillation with a fatal outcome
Introduction. Hemophagocytic syndrome (HS) after Bacillus Calmette-Guérin (BCG) immunotherapy is extremely rare in everyday practice. Only three cases of HS have been reported in the world until now. BCG is used for preventing the recurrence of superficial tumors of the urinary bladder. Severe compl...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Military Health Department, Ministry of Defance, Serbia
2023-01-01
|
Series: | Vojnosanitetski Pregled |
Subjects: | |
Online Access: | https://doiserbia.nb.rs/img/doi/0042-8450/2023/0042-84502200065S.pdf |